A Study of LY3540378 in Participants with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)
Phase 1
Recruiting
- Conditions
- Heart Failure, Heart Failure with Preserved Ejection FractionTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- CTIS2023-505902-40-00
- Lead Sponsor
- Eli Lilly & Co.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Have chronic heart failure
Exclusion Criteria
Have heart transplant, Have uncontrolled irregular heart beats, Have heart failure triggered by blood clot in lungs, Have stroke
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method